Controlled architectural and chemotactic studies of 3D cell migration

Biomaterials

Volumn 32, Issue 10, 2011, Pages 2634-2641

  Tayalia, Prakriti ^a   Mazur, Eric ^a   Mooney, David J ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

CCL19 gradient; Dendritic cells; Live imaging; Microfabrication; Scaffolds; Two photon polymerization

Indexed keywords

2-D SYSTEMS; 3D ARCHITECTURES; CCL19 GRADIENT; CELL ACTIVATION; CELL MIGRATION; DENDRITIC CELLS; END POINTS; EX-VIVO; IMMUNE CELLS; LIPOPOLYSACCHARIDES; LIVE IMAGING; MATRIX ARCHITECTURE; MICRO-FABRICATION TECHNIQUES; MIGRATION PROCESS; MODEL SYSTEM; NEW MODEL; REAL TIME; THEORETICAL MODELING; TISSUE DEVELOPMENT; TWO PHOTON POLYMERIZATION; VACCINE DEVELOPMENT; WOUND REPAIR;

ARCHITECTURE; BIOCHEMISTRY; CELLS; CYTOLOGY; DRUG DELIVERY; MICROANALYSIS; MICROFABRICATION; MICROMACHINING; MULTIPHOTON PROCESSES; PHOTONS; PHYSIOLOGICAL MODELS; POLYMERIZATION; SCAFFOLDS;

THREE DIMENSIONAL;

TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CHEMOTAXIS; DENDRITIC CELL; EX VIVO STUDY; MICROTECHNOLOGY; MOUSE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; THEORETICAL MODEL; THREE DIMENSIONAL IMAGING;

ANIMALS; CHEMOKINES; CHEMOTAXIS; DENDRITIC CELLS; FLOW CYTOMETRY; MICE; MICE, INBRED C57BL; MICROTECHNOLOGY; MODELS, BIOLOGICAL; RATS; SIGNAL TRANSDUCTION; TISSUE SCAFFOLDS;

EID: 79251599292     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.12.019     Document Type: Article

References (37)

1. Driever W., Nussleinvolhard C. A gradient of bicoid protein in drosophila embryos. Cell 1988, 54(1):83-93.
2. Ochoa O., Torres F.M., Shireman P.K. Chemokines and diabetic wound healing. Vascular 2007, 15(6):350-355.
3. Boyden S. Chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 1962, 115(3):453-466.
4. Nelson R.D., Quie P.G., Simmons R.L. Chemotaxis under agarose - new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 1975, 115(6):1650-1656.
5. Zigmond S.H. Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. J Cell Biol 1977, 75(2):606-616.
6. Zigmond S.H., Hirsch J.G. Leukocyte locomotion and chemotaxis - new methods for evaluation and demonstration of a cell-derived chemotactic factor. J Exp Med 1973, 137(2):387-410.
7. Zicha D., Dunn G.A., Brown A.F. A new direct-viewing chemotaxis chamber. J Cell Sci 1991, 99:769-775.
8. Gerisch G., Keller H.U. Chemotactic reorientation of granulocytes stimulated with micropipets containing fMet-Leu-Phe. J Cell Sci 1981, 52:1-10.
9. Rosoff W.J., McAllister R., Esrick M.A., Goodhill G.J., Urbach J.S. Generating controlled molecular gradients in 3D gels. Biotechnol Bioeng 2005, 91(6):754-759.
10. Wells A., Kassis J., Solava J., Turner T., Lauffenburger D.A. Growth factor-induced cell motility in tumor invasion. Acta Oncol 2002, 41(2):124-130.
11. Wilkinson P.C. Assays of leukocyte locomotion and chemotaxis. J Immunol Methods 1998, 216(1-2):139-153.
12. Cao X., Shoichet M.S. Defining the concentration gradient of nerve growth factor for guided neurite outgrowth. Neuroscience 2001, 103(3):831-840.
13. Fisher P.R., Merkl R., Gerisch G. Quantitative-analysis of cell motility and chemotaxis in dictyostelium-discoideum by using an image-processing system and a novel chemotaxis chamber providing stationary chemical gradients. J Cell Biol 1989, 108(3):973-984.
14. Dertinger S.K.W., Chiu D.T., Jeon N.L., Whitesides G.M. Generation of gradients having complex shapes using microfluidic networks. Anal Chem 2001, 73(6):1240-1246.
15. Jeon N.L., Dertinger S.K.W., Chiu D.T., Choi I.S., Stroock A.D., Whitesides G.M. Generation of solution and surface gradients using microfluidic systems. Langmuir 2000, 16(22):8311-8316.
16. Walker G.M., Sai J.Q., Richmond A., Stremler M., Chung C.Y., Wikswo J.P. Effects of flow and diffusion on chemotaxis studies in a microfabricated gradient generator. Lab Chip 2005, 5(6):611-618.
17. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392(6673):245-252.
18. Sozzani S., Allavena P., D'Amico G., Luini W., Bianchi G., Kataura M., et al. Cutting edge: differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 1998, 161(3):1083-1086.
19. Yanagihara S., Komura E., Nagafune J., Watarai H., Yamaguchi Y. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J Immunol 1998, 161(6):3096-3102.
20. Forster R., Schubel A., Breitfeld D., Kremmer E., Renner-Muller I., Wolf E., et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999, 99(1):23-33.
21. Sallusto F., Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 2000, 177:134-140.
22. Lutz M.B., Kukutsch N., Ogilvie A.L.J., Rossner S., Koch F., Romani N., et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999, 223(1):77-92.
23. Ali O.A., Mooney D.J. Sustained GM-CSF and PEI condensed pDNA presentation increases the level and duration of gene expression in dendritic cells. J Control Release 2008, 132(3):273-278.
24. Luft T., Jefford M., Luetjens P., Toy T., Hochrein H., Masterman K.A., et al. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E-2 regulates the migratory capacity of specific DC subsets. Blood 2002, 100(4):1362-1372.
25. Scandella E., Men Y., Gillessen S., Forster R., Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived denctritic cells. Blood 2002, 100(4):1354-1361.
26. Tayalia P., Mendonca C.R., Baldacchini T., Mooney D.J., Mazur E. 3D cell-migration studies using two-photon engineered polymer scaffolds. Adv Mater 2008, 20(23):4494-4498.
27. Krautwald S., Ziegler E., Forster R., Ohl L., Amann K., Kunzendorf U. Ectopic expression of CCL19 impairs alloimmune response in mice. Immunology 2004, 112(2):301-309.
28. Moghe P.V., Nelson R.D., Tranquillo R.T. Cytokine-stimulated chemotaxis of human neutrophils in a 3D conjoined fibrin gel assay. J Immunol Methods 1995, 180(2):193-211.
29. Coutu D.L., Yousefi A.M., Galipeau J. Three-dimensional porous scaffolds at the crossroads of tissue engineering and cell-based gene therapy. J Cell Biochem 2009, 108(3):537-546.
30. Yang Y., El Haj A.J. Biodegradable scaffolds - delivery systems for cell therapies. Expert Opin Biol Ther 2006, 6(5):485-498.
31. James N., Kara K., Richard W., Elizabeth O.Q., Matthew W., Barbara B., et al. A discrete cell migration model. Proceedings of the 2007 summer computer simulation conference 2007, Society for Computer simulation International, San Diego, California.
32. Varona R., Zaballos A., Gutierrez J., Martin P., Roncal F., Albar J.P., et al. Molecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP-3 alpha. FEBS Lett 1998, 440(1-2):188-194.
33. Ali O.A., Huebsch N., Cao L., Dranoff G., Mooney D.J. Infection-mimicking materials to program dendritic cells in situ. Nat Mater 2009, 8(2):151-158.
34. Hori Y., Winans A.M., Huang C.C., Horrigan E.M., Irvine D.J. Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy. Biomaterials 2008, 29(27):3671-3682.
35. Burkus J.K., Transfeldt E.E., Kitchel S.H., Watkins R.G., Balderston R.A. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 2002, 27(21):2396-2408.
36. Hill E., Boontheekul T., Mooney D.J. Regulating activation of transplanted cells controls tissue regeneration. Proc Natl Acad Sci U S A 2006, 103(8):2494-2499.
37. Silva E.A., Kim E.S., Kong H.J., Mooney D.J. Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci U S A. 2008, 105(38):14347-14352.